Last reviewed · How we verify

10% povidone iodine

Cairo University · FDA-approved active Small molecule Quality 5/100

10% povidone iodine is a Small molecule drug developed by Cairo University. It is currently FDA-approved. Also known as: Betadine, betadine.

At a glance

Generic name10% povidone iodine
Also known asBetadine, betadine
SponsorCairo University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about 10% povidone iodine

What is 10% povidone iodine?

10% povidone iodine is a Small molecule drug developed by Cairo University.

Who makes 10% povidone iodine?

10% povidone iodine is developed and marketed by Cairo University (see full Cairo University pipeline at /company/cairo-university).

Is 10% povidone iodine also known as anything else?

10% povidone iodine is also known as Betadine, betadine.

What development phase is 10% povidone iodine in?

10% povidone iodine is FDA-approved (marketed).

Related